|
|
(22 intermediate revisions by the same user not shown) |
Line 1: |
Line 1: |
| {| class="wikitable"
| | ==Definition of Multivessel Disease== |
| ! !! Category !! Topic !! Calculators !! Purpose !! Author !! Reviewer !! Status
| | |
| |-
| | For AEGIS-II inclusion criteria #5, multivessel disease criteria can be met by findings on the cardiac catheterization for the index MI, a prior cardiac catheterization, or both: |
| | Formula || CARDIOLOGY || || 6 Minute Walk Distance || Calculates reference values for distance walked, as a measure of functional status. || || ||
| | * Index MI cardiac catheterization: 50% or greater stenosis of the left main or at least <b><u>2</u></b> coronary artery territories (LAD, LCX, RCA) (prior to any interventions performed) |
| |-
| | * Prior cardiac catheterization: 50% or greater stenosis of left main or at least <b><u>2</u></b> coronary artery territories (LAD, LCx, RCA) (prior to any interventions performed) |
| | Formula || CARDIOLOGY || || Absolute Reticulocyte Count & Reticulocyte Index || Assesses appropriate response to anemia, frequently in sickle cell patients. || || || Tier 2
| | * Both: Index MI cardiac catheterization with 1 vessel with 50% or greater stenosis (prior to any interventions performed) <b><u>AND</u></b> prior PCI of at least 1 vessel different from index MI vessel |
| |-
| | * Prior multivessel CABG |
| | || CARDIOLOGY || || ACC/AHA Heart Failure Staging || Describes stages of heart failure and provides recommendations for therapy by stage. || || || Tier 1
| | |
| |-
| | Multivessel disease requires a 50% or greater stenosis in at least 2 of the 3 major epicardial artery territories (LAD, LCx, RCA) or the left main vessel. Branch vessel disease may qualify as part of the territory of that branch vessel (for example, a diagonal vessel is considered part of the LAD territory). For the purpose of this study, the ramus is considered part of the Left Circumflex artery territory. If a branch vessel is used as a qualifying vessel, that branch should be of large enough size to potentially undergo revascularization if clinically indicated, e.g. >2mm vessel size. |
| | Formula || CARDIOLOGY || Coronary artery disease || ACEF II risk score for cardiac surgery || || || ||
| | |
| |-
| | ==MVD Tool== |
| | || CARDIOLOGY || Coronary artery disease || ACTION ICU score for intensive care in NSTEMI || Predicts risk of NSTEMI complications requiring ICU care. || || || Tier 2
| | |
| |-
| | {| |
| | || CARDIOLOGY || || Acute Decompensated Heart Failure National Registry (ADHERE) Algorithm || Predicts in-hospital mortality in patients with heart failure (HF). || || ||
| | {{#Widget:MVD5}} |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || ADAPT protocol for cardiac event risk || || || || Tier 2
| |
| |-
| |
| | || CARDIOLOGY || DVT || AMUSE score calculator || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Aortic dissection detection risk score (ADD-RS) || || || || Tier 2
| |
| |-
| |
| | || CARDIOLOGY || || ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || ASCVD (Atherosclerotic Cardiovascular Disease) Risk Algorithm including Known ASCVD from AHA/ACC || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || ASTRAL Score for Ischemic StrokeUPDATED || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || ATRIA Bleeding Risk Score || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || ATRIA Stroke Risk Score || || || ||
| |
| |-
| |
| | || CARDIOLOGY || PE || Bova score for pulmonary embolism complications || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || || Brugada Criteria for Ventricular Tachycardia || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || CAGE Questions for Alcohol Use || || || ||
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Canadian Cardiovascular Society (CCS) angina grade || || || || Tier 2
| |
| |-
| |
| | || CARDIOLOGY || || Canadian Syncope Risk Score || || || ||
| |
| |-
| |
| | || CARDIOLOGY || VTE || Caprini score calculator || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | || CARDIOLOGY || || Cardiac Anesthesia Risk Evaluation Score (CARE) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Cardiac Output (Fick’s Formula) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || CART (Cardiac Arrest Risk Triage) Score || || || ||
| |
| |-
| |
| | Popular || CARDIOLOGY || Atrial fibrillation || CHA2DS2-VASc Score || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | Popular || CARDIOLOGY || Atrial fibrillation || CHADS2 score || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | || CARDIOLOGY || || Charlson Comorbidity Index (CCI) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Cincinnati Prehospital Stroke Severity Scale (CP-SSS) || || || ||
| |
| |-
| |
| | Formula || CARDIOLOGY || ECG || Corrected QT interval (QTc) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || CRUSADE score for post-mi bleeding risk || || || || Tier 2
| |
| |-
| |
| | || CARDIOLOGY || VTE || Dash prediction score for recurrent vte || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Dual Antiplatelet Therapy (DAPT) score || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || || Duke Activity Status Index (DASI) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Duke Criteria for Infective Endocarditis || || || ||
| |
| |-
| |
| | Formula || CARDIOLOGY || Coronary artery disease || Duke treadmill score || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope || || || ||
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Emergency Department Assessment of Chest Pain Score (EDACS) || || || || Tier 2
| |
| |-
| |
| | || CARDIOLOGY || || Emergency Heart Failure Mortality Risk Grade (EHMRG) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Framingham Heart Failure Diagnostic Criteria || || || ||
| |
| |-
| |
| | Formula || CARDIOLOGY || Coronary artery disease || Framingham Risk Score for hard coronary heart disease || || || ||
| |
| |-
| |
| | || CARDIOLOGY || PE || Geneva score calculator || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | || CARDIOLOGY || || GO-FAR (Good Outcome Following Attempted Resuscitation) Score || || || ||
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Grace Risk Score for All-Cause Mortality From Discharge to 6 Months || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Grace Risk Score for In-Hospital Mortality || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || || Gupta Perioperative Risk for Myocardial Infarction or Cardiac Arrest (MICA) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || GWTG-Heart Failure Risk Score || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || H2FPEF Score for Heart Failure with Preserved Ejection FractionNEW || || || ||
| |
| |-
| |
| | || CARDIOLOGY || DVT || HAMILTON score calculator || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | Popular || CARDIOLOGY || Atrial fibrillation || HAS-BLED score || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | || CARDIOLOGY || || HEART Pathway for Early Discharge in Acute Chest Pain || || || ||
| |
| |-
| |
| | Popular || CARDIOLOGY || MACE || HEART score for major cardiac events || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || || HEMORR₂HAGES Score for Major Bleeding Risk || || || ||
| |
| |-
| |
| | || CARDIOLOGY || VTE || HERDOO2 rule for discontinuing anticoagulation in unprovoked vte || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || PE || Hestia criteria for outpatient pulmonary embolism treatment || || || || Tier 2
| |
| |-
| |
| | || CARDIOLOGY || Bleeding || IMPROVE bleeding risk score || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || VTE || IMPROVE risk score calculator || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | || CARDIOLOGY || VTE || IMPROVEDD risk score calculator || || Sadaf Sharfaei || || Complete
| |
| |-
| |
| | || CARDIOLOGY || || Indian Takayasu Clinical Activity Score (ITAS2010) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Infective Endocarditis (IE) Mortality Risk Score || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Jones Criteria for Acute Rheumatic Fever Diagnosis || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Kawasaki Disease Diagnostic Criteria || || || ||
| |
| |-
| |
| | || CARDIOLOGY || VTE || Khorana risk score for venous thromboembolism in cancer patients || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Killip classification for heart failure || || || || Tier 2
| |
| |-
| |
| | || CARDIOLOGY || || LACE Index for Readmission || || || ||
| |
| |-
| |
| | Formula || CARDIOLOGY || Coronary artery disease || LDL calculated || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Light's Criteria for Exudative Effusions || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || MAGGIC Risk Calculator for Heart Failure || || || ||
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Marburg Heart Score (MHS) || || || || Tier 1
| |
| |-
| |
| | Formula || CARDIOLOGY || Blood pressure || Mean Arterial Pressure (MAP) || || || ||
| |
| |-
| |
| | || CARDIOLOGY || || Mehran Score for Post-PCI Contrast Nephropathy || || || ||
| |
| |-
| |
| | || CARDIOLOGY || VTE || Michigan risk score for picc-related thrombosis || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || || mMRC (Modified Medical Research Council) Dyspnea Scale || || || ||
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || Modified Early Warning Score (MEWS) for clinical deterioration || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || || Modified SOAR Score for Stroke || || || ||
| |
| |-
| |
| | || CARDIOLOGY || DVT || Modified Wells score calculator for DVT || || Sadaf Sharfaei || || Complete | |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || National Early Warning Score (NEWS) || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || Coronary artery disease || National Early Warning Score (NEWS) 2 || || || || Tier 1
| |
| |-
| |
| | || CARDIOLOGY || || Newsom Score for Non-traumatic Chest Pain || || || ||
| |
| |} | | |} |